Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
Jack Jr CR, Petersen RC, O'Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42, 183-188.
Fox NC, Scahill RI, Crum WR, Rossor MN (1999) Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 52, 1687-1689.
Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, George A (1997) Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 18, 131-138.
Shi F, Liu B, Zhou Y, Yu C, Jiang T (2009) Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus 19, 1055-1064.
Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in probable Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55, 967-972.
Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS (2002) MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58, 1188-1196.
Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72, 491-497.
Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ (2007) Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 68, 828-836.
Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC (2008) Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: A review. J Am Geriatr Soc 56, 920-934.
Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 33, 825 e825-836.
O'Brien JT (2007) Role of imaging techniques in the diagnosis of dementia. Br J Radiol 80(Spec No 2), S71-77.
Jack Jr CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591-600.
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack Jr CR, SchuffN,WeinerMW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative (2009) Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30, 2766-2788.
Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC (2008) Volumetric MRI and cognitive measures in Alzheimer disease : Comparison of markers of progression. J Neurol 255, 567-574.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
Jack Jr CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, PhelpsCH (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Associationworkgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 257-262.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack Jr CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M,Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
Augustinack JC, Huber KE, Postelnicu GM, Kakunoori S, Wang R, van der Kouwe AJ, Wald LL, Stein TD, Frosch MP, Fischl B (2012) Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: A combined neuropathology and high-resolution ex vivo MRI analysis. Acta Neuropathol 123, 85-96.
Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A, dNeuroMed Consortium (2013) Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. J Alzheimers Dis 33, 755-766.
Bakkour A, Morris JC, Wolk DA, Dickerson BC (2013) The effects of aging and Alzheimer's disease on cerebral cortical anatomy: Specificity and differential relationships with cognition. Neuroimage 76, 332-344.
Plant C, Teipel SJ, Oswald A, Bohm C, Meindl T, Mourao-Miranda J, Bokde AW, Hampel H, Ewers M (2010) Automated detection of brain atrophy patterns based onMRI for the prediction of Alzheimer's disease. Neuroimage 50, 162-174.
Wang L, Miller JP, Gado MH,McKeel DW, Rothermich M, Miller MI,Morris JC, Csernansky JG (2006) Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage 30, 52-60.
Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM, Alzheimer's Disease Neuroimaging Initiative (2009) Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 106, 20954-20959.
Jack Jr CR, Shiung MM,Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65, 1227-1231.
Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E (1998) Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study. Neurology 51, 357-362.
Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, Gunter JL, Senjem ML, Vemuri P, Smith GE, Geda YE, Graff-Radford J, Knopman DS, Petersen RC, Parisi JE, Dickson DW, Jack Jr CR, Kantarci K (2015) Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging 36, 452-461.
Schott JM, Crutch SJ, Frost C,Warrington EK, Rossor MN, Fox NC (2008) Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia 46, 1732-1737.
Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, Vrenken H (2008) Whole-brain atrophy rate and cognitive decline: Longitudinal MR study of memory clinic patients. Radiology 248, 590-598.
Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008) Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors. Neurology 70, 1836-1841.
Josephs KA, Whitwell JL, Ahmed Z, Shiung MM,Weigand SD, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Dickson DW, Jack Jr CR (2008) Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63, 204-212.
Frisoni GB, Fox NC, Jack Jr CR, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6, 67-77.
Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, Frost C, Scahill RI, Fox NC (2008) A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage 40, 1655-1671.
Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, deToledo-Morrell L, Killiany RJ, Lehericy S, Pantel J, Pruessner JC, Soininen H, Watson C, Duchesne S, Jack Jr CR, Frisoni GB (2011) Survey of protocols for the manual segmentation of the hippocampus: Preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis 26(Suppl 3), 61-75.
Jack Jr CR, Theodore WH, Cook M, McCarthy G (1995) MRI-based hippocampal volumetrics: Data acquisition, normal ranges, and optimal protocol. Magn Reson Imaging 13, 1057-1064.
Ghanei A, Soltanian-Zadeh H,Windham JP (1998) Segmentation of the hippocampus from brainMRIusing deformable contours. Comput Med Imaging Graph 22, 203-216.
Haller JW, Banerjee A, Christensen GE, Gado M, Joshi S, Miller MI, Sheline Y, Vannier MW, Csernansky JG (1997) Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology 202, 504-510.
Freeborough PA, Fox NC, Kitney RI (1997) Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 53, 15-25.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1), S208-219.
Dale AM, Fischl B, Sereno MI (1999) Cortical surfacebased analysis. I. Segmentation and surface reconstruction. Neuroimage 9, 179-194.
Fischl B, Sereno MI, Dale AM (1999) Cortical surfacebased analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195-207.
Brewer JB, Magda S, Airriess C, Smith ME (2009) Fullyautomated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 30, 578-580.
BrainVISA Anatomist. http://brainvisa. info
Smeets D, Ribbens A, Sima DM, Cambron M, Horakova D, Jain S, Maertens A, Van Vlierberghe E, Terzopoulos V, Van Binst AM, Vaneckova M, Krasensky J, Uher T, Seidl Z, De Keyser J, Nagels G, De Mey J, Havrdova E, Van Hecke W (2016) Reliable measurements of brain atrophy in individual patients with multiple sclerosis. Brain Behav 6, e00518.
Lysandropoulos AP, Absil J, Metens T, Mavroudakis N, Guisset F, Van Vlierberghe E, Smeets D, David P, Maertens A, Van Hecke W (2016) Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice-comparison of 1. 5 and 3 Tesla magnetic resonance imaging. Brain Behav 6, e00422.
Jain S, Ribbens A, Sima DM, Cambron M, De Keyser J, Wang C, Barnett MH, Van Huffel S, Maes F, Smeets D (2016) Two time point MS lesion segmentation in brain MRI: An expectation-maximization framework. Front Neurosci 10, 576.
Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van HeckeW, DeMey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D (2015) Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin 8, 367-375.
Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H (2017) Agreement of MSmetrix with established methods for measuring crosssectional and longitudinal brain atrophy. Neuroimage Clin 15, 843-853.
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, MielkeMM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M, Subjective Cognitive Decline Initiative Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 10, 844-852.
Sorensen L, Igel C, Pai A, Balas I, Anker C, Lillholm M, Nielsen M, Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing (2017) Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry. Neuroimage Clin 13, 470-482.
Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack Jr CR, Ashburner J, Frackowiak RS (2008) Automatic classification of MR scans in Alzheimer's disease. Brain 131, 681-689.
Frisoni GB, Bocchetta M, Chetelat G, Rabinovici GD, de Leon MJ, Kaye J, ReimanEM,Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack Jr CR, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, ThiesW,Wahlund LO,WeinerMW, Pasqualetti P, Decarli C, ISTAART's NeuroImaging Professional Interest Area (2013) Imaging markers for Alzheimer disease: Which vs how. Neurology 81, 487-500.
Gunning-Dixon FM, Raz N (2003) Neuroanatomical correlates of selected executive functions in middle-aged and older adults: A prospective MRI study. Neuropsychologia 41, 1929-1941.
Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, Rosseel Y, Janowitz D, Doshi J, Van der Auwera S, von Sarnowski B, Hegenscheid K, Hosten N, Homuth G, VolzkeH, SchminkeU, HoffmannW, Grabe HJ, Davatzikos C (2016) White matter hyperintensities and imaging patterns of brain ageing in the general population. Brain 139, 1164-1179.
Sun Z, van de Giessen M, Lelieveldt BP, Staring M (2017) Detection of conversion from mild cognitive impairment to Alzheimer's disease using longitudinal brain MRI. Front Neuroinform 11, 16.
Smith SM, De Stefano N, Jenkinson M, Matthews PM (2001) Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr 25, 466-475.
Freeborough PA, Fox NC (1997) The boundary shift integral: An accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 16, 623-629.
Boyes RG, Rueckert D, Aljabar P, Whitwell J, Schott JM, Hill DL, Fox NC (2006) Cerebral atrophy measurements using Jacobian integration: Comparison with the boundary shift integral. Neuroimage 32, 159-169.
Sluimer JD, Bouwman FH, Vrenken H, Blankenstein MA, Barkhof F, van der Flier WM, Scheltens P (2010) Wholebrain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study. Neurobiol Aging 31, 758-764.
Jack Jr CR, Lowe VJ,Weigand SD,Wiste HJ, Senjem ML, Knopman DS, ShiungMM,Gunter JL, Boeve BF,Kemp BJ, Weiner M, Petersen RC, Alzheimer's Disease Neuroimaging Initiative (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain 132, 1355-1365.
Evans MC, Barnes J, Nielsen C, Kim LG, Clegg SL, Blair M, Leung KK, Douiri A, Boyes RG, Ourselin S, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2010) Volume changes in Alzheimer's disease and mild cognitive impairment: Cognitive associations. Eur Radiol 20, 674-682.
Verlinden VJ, van der Geest JN, Hofman A, Niessen WJ, van der Lugt A, Vernooij MW, Ikram MA (2017) Brain MRI-markers associate differentially with cognitive versus functional decline leading to dementia. J Am Geriatr Soc 65, 1258-1266.
Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC (2002) Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 59, 867-873.
Kovacevic S, Rafii MS, Brewer JB, Alzheimer's Disease Neuroimaging Initiative (2009) High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 23, 139-145.
